WARPTECHNEWS · LAB
HomeAIBusinessTechArchive
WARPTECH LAB NEWS

Warptech Lab News aggrega le notizie più rilevanti da oltre 700 fonti internazionali, con classificazione AI, TL;DR sintetici e timeline cluster su singole storie.

Navigazione

  • Home
  • Archivio
  • Editor's Brief
  • Cerca
  • Il tuo account
  • Newsletter tech/AI

Informazioni legali

  • Privacy Policy
  • Termini di servizio
  • Cookie Policy

© 2026 Sparktech S.R.L. — Tutti i diritti riservati. Sito gestito e manutenuto da Sparktech S.R.L.

Sede legale: Corso Libertà 55, 13100 Vercelli (VC), Italia · P.IVA / C.F. 02835910023 · Contatti: admin@warptechlab.com

Home
Storia in 3 fonti

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

Raccontata datheguardian.comtelegraph.co.uknytimes.com

Confronto fonti

3 prospettive sulla stessa storia
AI · summaries
nytimes.comStai leggendo10 mesi fa

How Ozempic Maker Novo Nordisk Lost Its Shine

The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.

originale
telegraph.co.uk10 mesi fa

The amazing rise and shocking fall of the company that created Ozempic

A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

Leggi questa versione → originale

Timeline cronologica

  1. mercoledì 6 agosto 2025·theguardian.com

    Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

    Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

  2. mercoledì 6 agosto 2025·telegraph.co.uk

    The amazing rise and shocking fall of the company that created Ozempic

    A string of blunders led to the value of Novo Nordisk dropping £52bn last week. Could a new weight-loss pill help it regain its crown?

theguardian.com10 mesi fa

Sales of Novo Nordisk’s diabetes drugs including Ozempic slow sharply

Fierce competition and threat of Trump tariffs lead to Danish company cutting costs

Leggi questa versione → originale
  • giovedì 7 agosto 2025·nytimes.com

    How Ozempic Maker Novo Nordisk Lost Its Shine

    The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed its fortunes.